Download Oncology Nursing Drug Handbook - v3.5.13

Lets download and share Oncology Nursing Drug Handbook - v3.5.13, one of the featured APPS in the categoryMedical.
Plus, some other APPS that you can download as X-RAY WOW, Dexcom G6, MCQ Abubakr (ASU), iDentist Dental practice management, Jan Aushadhi Sugam (BPPI), ALAT. If you feel satisfied with Oncology Nursing Drug Handbook - v3.5.13.

Released by Skyscape Medpresso Inc, Oncology Nursing Drug Handbook - v3.5.13 is one of the best free and best mobile phone applications available today. Located in the Medical category of the app store.

The minimum operating system for Oncology Nursing Drug Handbook - v3.5.13 is Android 5.0+ and up. So you have to update your phone if you haven't already.

At APKDroid, you will get Oncology Nursing Drug Handbook - v3.5.13 APK free download, with the latest version being 3.5.13, publication date 2020-06-25, the file size is 8.4 MB.According to statistics from the Google Play Store, there are about 1000 downloads. Apps downloaded or installed individually on Android can be updated if you wish. Update your apps as well. Grants you access to the latest features and improves the security and stability of the app. Enjoy it now !!!

Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features

- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)

Faster download with slow internet connectivity